February 2024 – Integrating genetic information from >520,000 individuals with data from plasma proteomics, the team of Marios Georgakis identified a proteomic signature of IL-6 signaling activation and mediators of its effects on cardiovascular disease. Their analyses suggest, that the interferon-γ-inducible chemokine CXCL10 is a potentially causal mediator for atherosclerosis in different vascular beds (coronary, cerebral, and peripheral arteries) and could serve as a promising drug target for atheroprotection.
Murad Omarov presenting his work at the meeting of the International Stroke Genetic Consortium (ISGC).
April 2024 – Murad presented his work on deep learning analyses of carotid ultrasound images at the ISGC meeting in Munich.
